MCI is First to Use the Aveir™ VR Leadless Pacemaker at EEH
NAPERVILLE, IL– Dr. Kousik Krishnan, electrophysiologist at Midwest Cardiovascular Institute (MCI), is the first to use the Abbott Aveir™ VR Leadless Pacemaker to treat abnormal heart rhythm at Edward-Elmhurst Health (EEH).
A leadless pacemaker is a small, battery-powered device with no wires that delivers electrical energy to the heart to keep it in regular rhythm. Manufactured by Abbott, the Aveir™ VR Leadless Pacemaker (LP) is the next evolution in leadless technology that has been designed for chronic retrieval. At just 38.0 mm and smaller than an AAA battery, the Aveir™ VR LP features up to twice the projected battery life compared to other leadless pacemakers when using ISO standard settings and brings fewer lead-related complications compared to transvenous pacemakers with wires. It also offers mapping capability to assess correct placement of the device before final fixation within the heart, and is designed to be enabled by future software to support a dual-chamber pacing system upon regulatory approval.
“We want our patients to not only live longer, but better,” said Dr. Krishnan. “The entire electrophysiology team at Edward Elmhurst Health is proud to offer this new technology to patients in need of a pacemaker. It is a game-changer for our patients due to no lead-related complications, future upgradeability, and fewer restrictions post-implant.”